 |
50 Diseases |  |
11 Trials |
|
11 Trials |  |
833 News |  |
| «123456789101112» |
- ||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New trial: Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements (clinicaltrials.gov) - Mar 4, 2016
P=N/A, N=200, Recruiting, Sponsor: University of Illinois at Chicago
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=44, Recruiting, Sponsor: Daniel S. Berman
Trial primary completion date: Dec 2014 --> Feb 2017
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date, MRI: Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging (clinicaltrials.gov) - Jan 17, 2016
P4, N=40, Recruiting, Sponsor: Timothy M. Bateman
Trial primary completion date: Dec 2014 --> Feb 2017 Trial primary completion date: Jan 2016 --> Oct 2016
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P2 trial: Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging (clinicaltrials.gov) - Dec 11, 2015
P2, N=75, Recruiting, Sponsor: University of Cincinnati
- || Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Stress Testing and Cardiac Magnetic Resonance (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=525, Recruiting, Sponsor: University of Chicago
Trial primary completion date: Jan 2016 --> Oct 2016 Trial primary completion date: Apr 2014 --> Apr 2020
- |||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: HFpEF-PRoF: Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF (clinicaltrials.gov) - Dec 5, 2015
P4, N=60, Recruiting, Sponsor: Marvin W. Kronenberg, M.D.
Trial primary completion date: Apr 2014 --> Apr 2020 Not yet recruiting --> Recruiting
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration (clinicaltrials.gov) - Nov 25, 2015
P0, N=5, Recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting --> Recruiting Trial primary completion date: Feb 2016 --> Jul 2016
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New trial: Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging (clinicaltrials.gov) - Nov 21, 2015
P=N/A, N=20, Recruiting, Sponsor: University of Utah
- || Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: RVuptakeLexi: Stress Induced Right Ventricular Uptake on Lexiscan Stress MPI (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=650, Enrolling by invitation, Sponsor: Aiden Abidov
Trial primary completion date: Feb 2016 --> Jul 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P4 trial: Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction (clinicaltrials.gov) - Nov 6, 2015
P4, N=40, Not yet recruiting, Sponsor: Patricia Kim Phuong Nguyen
- ||||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P4 trial: HFpEF-PRoF: Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF (clinicaltrials.gov) - Oct 28, 2015
P4, N=60, Not yet recruiting, Sponsor: Marvin W. Kronenberg, M.D.
- ||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion, Enrollment change, Trial primary completion date: Intravenous Regadenoson Versus Intravenous Adenoscan (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=64, Completed, Sponsor: Ochsner Health System
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Completed | N=48 --> 64 | Trial primary completion date: Aug 2014 --> May 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Characterization of Myocardial Blood Flow Measurements Using Lexiscan (clinicaltrials.gov) - Aug 21, 2015
P4, N=60, Recruiting, Sponsor: Timothy M. Bateman, MD
Recruiting --> Completed | N=48 --> 64 | Trial primary completion date: Aug 2014 --> May 2014 Trial primary completion date: Sep 2015 --> Jan 2016
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: A Phase II Trial of Regadenoson in Sickle Cell Anemia (clinicaltrials.gov) - Aug 13, 2015
P2, N=96, Recruiting, Sponsor: Dana-Farber Cancer Institute
Trial primary completion date: Sep 2015 --> Jan 2016 Trial primary completion date: Apr 2015 --> Jun 2016
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion, Trial primary completion date: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (clinicaltrials.gov) - Jul 9, 2015
P4, N=16, Completed, Sponsor: Washington University School of Medicine
Trial primary completion date: Apr 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jun 2015
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET (clinicaltrials.gov) - Jun 29, 2015
P4, N=50, Recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jun 2015 Trial primary completion date: Jul 2015 --> May 2016
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=80, Recruiting, Sponsor: University of Cincinnati
Trial primary completion date: Jul 2015 --> May 2016 Trial primary completion date: Aug 2013 --> Sep 2015
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial initiation date, Trial primary completion date: Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers (clinicaltrials.gov) - Jun 11, 2015
P1, N=145, Recruiting, Sponsor: University of Michigan
Trial primary completion date: Aug 2013 --> Sep 2015 Initiation date: Aug 2011 --> Nov 2011 | Trial primary completion date: Aug 2016 --> Sep 2018
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment change: Microvascular Blood Flow in Sickle Cell Anemia (clinicaltrials.gov) - Apr 20, 2015
P=N/A, N=200, Recruiting, Sponsor: Blood Center of Wisconsin
Initiation date: Aug 2011 --> Nov 2011 | Trial primary completion date: Aug 2016 --> Sep 2018 N=103 --> 200
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion, Trial primary completion date: Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI (clinicaltrials.gov) - Mar 27, 2015
P2, N=20, Completed, Sponsor: Northwestern University
N=103 --> 200 Not yet recruiting --> Completed | Trial primary completion date: Aug 2013 --> Feb 2014
- ||||||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion: EXERRT: A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) (clinicaltrials.gov) - Dec 24, 2014
P3, N=1147, Completed, Sponsor: Astellas Pharma Global Development, Inc.
Not yet recruiting --> Completed | Trial primary completion date: Aug 2013 --> Feb 2014 Active, not recruiting --> Completed
- ||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: Stress CT Perfusion in Patients With Chest Pain (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=300, Recruiting, Sponsor: University of Chicago
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (clinicaltrials.gov) - Dec 10, 2014
P4, N=15, Recruiting, Sponsor: Washington University School of Medicine
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET (clinicaltrials.gov) - Nov 24, 2014
P4, N=50, Recruiting, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Recruiting Trial primary completion date: Jul 2014 --> Jul 2015
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open, Trial initiation date, MRI: Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging (clinicaltrials.gov) - Oct 31, 2014
P4, N=40, Recruiting, Sponsor: Timothy M. Bateman
Trial primary completion date: Jul 2014 --> Jul 2015 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Aug 2014
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion, Enrollment change: Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=33, Completed, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Aug 2014 Recruiting --> Completed | N=50 --> 33
- || Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Lexi-Echo: Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=380, Active, not recruiting, Sponsor: Aiden Abidov
Recruiting --> Completed | N=50 --> 33 Trial primary completion date: Dec 2013 --> Nov 2014
- |||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking (clinicaltrials.gov) - Sep 4, 2014
P4, N=300, Recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2013 --> Nov 2014 Not yet recruiting --> Recruiting
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Characterization of Myocardial Blood Flow Measurements Using Lexiscan (clinicaltrials.gov) - Jul 23, 2014
P4, N=60, Recruiting, Sponsor: Timothy M. Bateman, MD
Not yet recruiting --> Recruiting Trial primary completion date: Aug 2014 --> Sep 2015
- || Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Stress CT Perfusion in Patients With Chest Pain (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=300, Not yet recruiting, Sponsor: University of Chicago
Trial primary completion date: Aug 2014 --> Sep 2015 Trial primary completion date: Dec 2016 --> Jun 2017
- || Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial initiation date: Stress CT Perfusion in Patients With Chest Pain (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=300, Not yet recruiting, Sponsor: University of Chicago
Trial primary completion date: Dec 2016 --> Jun 2017 Initiation date: Jan 2014 --> Jun 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial withdrawal: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - May 28, 2014
P2, N=0, Withdrawn, Sponsor: Emory University
Initiation date: Jan 2014 --> Jun 2014 Terminated --> Withdrawn
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - May 27, 2014
P2, N=2, Terminated, Sponsor: Emory University
Terminated --> Withdrawn Trial primary completion date: Sep 2014 --> May 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial primary completion date: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (clinicaltrials.gov) - May 27, 2014
P4, N=15, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Sep 2014 --> May 2014 Trial primary completion date: Jan 2014 --> Dec 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial termination: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - May 27, 2014
P2, N=2, Terminated, Sponsor: Emory University
Trial primary completion date: Jan 2014 --> Dec 2014 Recruiting --> Terminated; PI leaving facility
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion date: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - May 27, 2014
P2, N=2, Terminated, Sponsor: Emory University
Recruiting --> Terminated; PI leaving facility Trial completion date: Sep 2014 --> May 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion date: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (clinicaltrials.gov) - May 27, 2014
P4, N=15, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial completion date: Sep 2014 --> May 2014 Trial completion date: Jan 2014 --> Dec 2014
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment change: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - May 27, 2014
P2, N=2, Terminated, Sponsor: Emory University
Trial completion date: Jan 2014 --> Dec 2014 N=50 --> 2
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment closed: Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (clinicaltrials.gov) - May 27, 2014
P4, N=15, Active, not recruiting, Sponsor: Washington University School of Medicine
N=50 --> 2 Recruiting --> Active, not recruiting
- ||||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P4 trial: Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking (clinicaltrials.gov) - May 2, 2014
P4, N=300, Not yet recruiting, Sponsor: M.D. Anderson Cancer Center
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P4 trial, MRI: Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging (clinicaltrials.gov) - Apr 14, 2014
P4, N=40, Not yet recruiting, Sponsor: Timothy M. Bateman
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
New P1 trial: Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla) (clinicaltrials.gov) - Mar 18, 2014
P1, N=340, Recruiting, Sponsor: Cedars-Sinai Medical Center
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial suspension: ASSUAGE-MPI: The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion (clinicaltrials.gov) - Mar 13, 2014
P4, N=60, Suspended, Sponsor: Rush University Medical Center
Recruiting --> Active, not recruiting Recruiting --> Suspended
- ||||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment closed: EXERRT: A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) (clinicaltrials.gov) - Feb 6, 2014
P3, N=1147, Active, not recruiting, Sponsor: Astellas Pharma Global Development, Inc.
Recruiting --> Suspended Recruiting --> Active, not recruiting
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: Characterization of Myocardial Blood Flow Measurements Using Lexiscan (clinicaltrials.gov) - Nov 19, 2013
P4, N=60, Recruiting, Sponsor: Timothy M. Bateman, MD
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial initiation date: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - Nov 18, 2013
P2, N=50, Recruiting, Sponsor: Emory University
Active, not recruiting --> Recruiting Initiation date: May 2013 --> Oct 2013
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Enrollment open: Phase Analysis and Obstructive CAD on Rubidium PET (clinicaltrials.gov) - Nov 18, 2013
P2, N=50, Recruiting, Sponsor: Emory University
Initiation date: May 2013 --> Oct 2013 Not yet recruiting --> Recruiting
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Trial completion: Regadenoson and Adenosine (clinicaltrials.gov) - Nov 10, 2013
P3, N=100, Completed, Sponsor: Lokien van Nunen
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Clinical: Stress CT Perfusion in Patients With Chest Pain (clinicaltrials.gov) - Oct 23, 2013
P=N/A, N=300, Not yet recruiting, Sponsor: University of Chicago
- Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Clinical: Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies (clinicaltrials.gov) - Sep 23, 2013
P=N/A, N=44, Recruiting, Sponsor: Daniel S. Berman